The budget's $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.
Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the Natio
Kristina Koveshnikova Wed, 11 Jul 2018
The budget’s $234 million boost to support business research and development is a “clever” investment that is bound to ripen hefty returns.
Brad Duft, president of CoDa Therapeutics, a company operating locally and in the US, told the National Business Review that New Zealand has tremendous
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
